No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.

作者: Jiyun An , Danbi Lee , Ju Hyun Shim , Kang Mo Kim , Han Chu Lee

DOI: 10.3350/CMH.2014.20.2.177

关键词: Interleukin 28BSNP arrayAlpha interferonImmunologyGenotypeAllele frequencySNPGastroenterologyRibavirinSingle-nucleotide polymorphismInternal medicineMedicine

摘要: BACKGROUND/AIMS There are few available data regarding the association between single nucleotide polymorphisms (SNPs) of gene encoding interleukin 28B (IL28B) and a sustained virologic response (SVR) to peginterferon (PEG-IFN) plus ribavirin (RBV) therapy in Korean chronic hepatitis C patients. METHODS This was retrospective cohort study 156 patients with virus (HCV) infection who received combination treatment PEG-IFN RBV. Blood samples from these were analyzed identify IL28B SNPs at rs12979860, rs12980275, rs8099917, rs8103142. Association analyses performed evaluate relationships each SNP SVRs. RESULTS Seventy six HCV genotype 1 80 non-1 enrolled. The frequencies rs12979860 CC CT genotypes 90.4% 9.6%, respectively; those rs12980275 AA AG 87.2% 12.8%, rs8099917 TT TG 92.3% 7.7%, rs8103142 respectively. Among 1, SVR rates 69.7% 80.0% for CT, respectively (P=0.71). patients, 88.0% 100% (P=1.00), CONCLUSIONS Genotypes that known be favorable present most this study. Moreover, did not influence rate either or Therefore, analysis might useful initial assessment, prediction outcomes, decision-making

参考文章(23)
J.-F. HUANG, M.-L. YU, C.-M. LEE, C.-Y. DAI, N.-J. HOU, M.-Y. HSIEH, J.-H. WANG, S.-N. LU, I.-S. SHEEN, S.-M. LIN, W.-L. CHUANG, Y.-F. LIAW, Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan Alimentary Pharmacology & Therapeutics. ,vol. 25, pp. 1029- 1037 ,(2007) , 10.1111/J.1365-2036.2007.03297.X
Dong Hyun Sinn, Su Rin Shin, Jae Sook Kil, Jeong Kim, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik, Efficacy of peg-interferon-α-2a plus ribavirin for patients aged 60 years and older with chronic hepatitis C in Korea. Journal of Gastroenterology and Hepatology. ,vol. 26, pp. 469- 476 ,(2011) , 10.1111/J.1440-1746.2010.06478.X
Janett Fischer, Stephan Böhm, Markus Scholz, Tobias Müller, Heiko Witt, Jacob George, Christoph Sarrazin, Simone Susser, Eckart Schott, Vijayaprakash Suppiah, David R. Booth, Graeme J. Stewart, Florian van Bömmel, Annika Brodzinski, Balazs Fülöp, Pascal Migaud, Thomas Berg, Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. Hepatology. ,vol. 55, pp. 1700- 1710 ,(2012) , 10.1002/HEP.25582
Dong Hyun Sinn, Yu Jin Kim, Seung-Tae Lee, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik, Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in Asian Patients Journal of Gastroenterology and Hepatology. ,vol. 26, pp. no- no ,(2011) , 10.1111/J.1440-1746.2011.06744.X
Giuseppe Indolfi, Melissa Sambrotta, Maria Moriondo, Chiara Azzari, Massimo Resti, None, Genetic variation in interleukin-28B locus is associated with spontaneous clearance of HCV in children with non-1 viral genotype infection. Hepatology. ,vol. 54, pp. 1490- 1491 ,(2011) , 10.1002/HEP.24482
Young Kul Jung, Ju Hyun Kim, Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C Clinical and molecular hepatology. ,vol. 19, pp. 26- 28 ,(2013) , 10.3350/CMH.2013.19.1.26
Andri Rauch, Zoltán Kutalik, Patrick Descombes, Tao Cai, Julia Di Iulio, Tobias Mueller, Murielle Bochud, Manuel Battegay, Enos Bernasconi, Jan Borovicka, Sara Colombo, Andreas Cerny, Jean–François Dufour, Hansjakob Furrer, Huldrych F. Günthard, Markus Heim, Bernard Hirschel, Raffaele Malinverni, Darius Moradpour, Beat Müllhaupt, Andrea Witteck, Jacques S. Beckmann, Thomas Berg, Sven Bergmann, Francesco Negro, Amalio Telenti, Pierre–Yves Bochud, Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study Gastroenterology. ,vol. 138, pp. 1338- 1345 ,(2010) , 10.1053/J.GASTRO.2009.12.056
Yasuhito Tanaka, Nao Nishida, Masaya Sugiyama, Masayuki Kurosaki, Kentaro Matsuura, Naoya Sakamoto, Mina Nakagawa, Masaaki Korenaga, Keisuke Hino, Shuhei Hige, Yoshito Ito, Eiji Mita, Eiji Tanaka, Satoshi Mochida, Yoshikazu Murawaki, Masao Honda, Akito Sakai, Yoichi Hiasa, Shuhei Nishiguchi, Asako Koike, Isao Sakaida, Masatoshi Imamura, Kiyoaki Ito, Koji Yano, Naohiko Masaki, Fuminaka Sugauchi, Namiki Izumi, Katsushi Tokunaga, Masashi Mizokami, Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nature Genetics. ,vol. 41, pp. 1105- 1109 ,(2009) , 10.1038/NG.449
Michael W. Fried, Mitchell L. Shiffman, K. Rajender Reddy, Coleman Smith, George Marinos, Fernando L. Gonçales, Dieter Häussinger, Moises Diago, Giampiero Carosi, Daniel Dhumeaux, Antonio Craxi, Amy Lin, Joseph Hoffman, Jian Yu, Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. The New England Journal of Medicine. ,vol. 347, pp. 975- 982 ,(2002) , 10.1056/NEJMOA020047
David L. Thomas, Chloe L. Thio, Maureen P. Martin, Ying Qi, Dongliang Ge, Colm O’hUigin, Judith Kidd, Kenneth Kidd, Salim I. Khakoo, Graeme Alexander, James J. Goedert, Gregory D. Kirk, Sharyne M. Donfield, Hugo R. Rosen, Leslie H. Tobler, Michael P. Busch, John G. McHutchison, David B. Goldstein, Mary Carrington, Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature. ,vol. 461, pp. 798- 801 ,(2009) , 10.1038/NATURE08463